Kenneth Dickstein Selected Research

Losartan (Cozaar)

1/2018	Stroke Risk in Patients With Reduced Ejection Fraction After Myocardial Infarction Without Atrial Fibrillation.
11/2012	A multi-center, double-blind, randomized, parallel group study to evaluate the effects of two different doses of losartan on morbidity and mortality in Chinese patients with symptomatic heart failure intolerant of angiotensin converting enzyme inhibitor treatment.
11/2009	Effects of high-dose versus low-dose losartan on clinical outcomes in patients with heart failure (HEAAL study): a randomised, double-blind trial.
1/2009	Erythropoietin levels in heart failure after an acute myocardial infarction: determinants, prognostic value, and the effects of captopril versus losartan.
9/2008	Design of the heart failure endpoint evaluation of AII-antagonist losartan (HEAAL) study in patients intolerant to ACE-inhibitor.
9/2007	Unrecognized glycometabolic disturbance as measured by hemoglobin A1c is associated with a poor outcome after acute myocardial infarction.
3/2007	Usefulness of either or both left and right bundle branch block at baseline or during follow-up for predicting death in patients following acute myocardial infarction.
7/2005	Recurrent infarction causes the most deaths following myocardial infarction with left ventricular dysfunction.
7/2005	Comparison of losartan and captopril on heart failure-related outcomes and symptoms from the losartan heart failure survival study (ELITE II).
6/2005	Soluble CD40 ligand in acute and chronic heart failure.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Kenneth Dickstein Research Topics

Disease

183	Heart Failure 01/2024 - 01/2001
40	Myocardial Infarction 12/2023 - 01/2001
15	Left Ventricular Dysfunction 01/2020 - 01/2001
14	Atrial Fibrillation 12/2023 - 10/2007
14	Inflammation (Inflammations) 09/2023 - 06/2005
11	Iron Deficiencies 01/2022 - 11/2009
9	Acute Coronary Syndrome 01/2023 - 12/2005
8	Type 2 Diabetes Mellitus (MODY) 01/2023 - 02/2006
8	Stroke (Strokes) 11/2022 - 09/2004
6	Cardiomyopathies (Cardiomyopathy) 01/2022 - 11/2005
6	Infarction (Infarctions) 01/2016 - 01/2001
5	Heart Diseases (Heart Disease) 12/2023 - 06/2003
5	Neoplasms (Cancer) 01/2023 - 11/2004
5	Hypertension (High Blood Pressure) 01/2023 - 06/2003
5	Necrosis 01/2023 - 11/2004
5	Dyspnea (Shortness of Breath) 08/2020 - 02/2009
4	Chronic Renal Insufficiency 01/2022 - 11/2016
4	Diabetes Mellitus 01/2021 - 11/2006
4	Hypotension (Low Blood Pressure) 01/2020 - 12/2012
3	Mitral Valve Insufficiency (Mitral Regurgitation) 12/2023 - 01/2016
3	Pulmonary Hypertension 10/2022 - 01/2013
3	Atherosclerosis 01/2020 - 06/2005
3	ST Elevation Myocardial Infarction 10/2017 - 05/2009
3	Cardiovascular Diseases (Cardiovascular Disease) 05/2017 - 09/2004
3	Ventricular Remodeling 09/2013 - 11/2009
2	Metabolic Syndrome (Dysmetabolic Syndrome X) 12/2023 - 01/2023
2	Fibrosis (Cirrhosis) 09/2023 - 01/2016
2	Coronary Artery Disease (Coronary Atherosclerosis) 01/2022 - 01/2017
2	Bundle-Branch Block (Fascicular Block) 08/2021 - 08/2020
2	Disease Progression 01/2020 - 01/2017
2	Anemia 01/2019 - 12/2009
2	Edema (Dropsy) 01/2019 - 08/2009
2	Sudden Death 12/2018 - 03/2010

Drug/Important Bio-Agent (IBA)

28	Brain Natriuretic Peptide (Natrecor)FDA Link 11/2023 - 09/2005
21	Biomarkers (Surrogate Marker)IBA 12/2023 - 11/2012
19	Angiotensin-Converting Enzyme Inhibitors (ACE Inhibitors)IBA 01/2023 - 01/2001
15	pro-brain natriuretic peptide (1-76)IBA 09/2023 - 05/2009
12	aliskiren FDA Link 01/2023 - 01/2011
12	Angiotensin Receptor AntagonistsIBA 06/2021 - 01/2001
12	Losartan (Cozaar)FDA LinkGeneric 01/2018 - 01/2001
11	Natriuretic PeptidesIBA 01/2023 - 09/2005
10	Peptidyl-Dipeptidase A (Angiotensin Converting Enzyme)IBA 10/2019 - 01/2001
8	CreatinineIBA 08/2021 - 09/2004
8	Captopril (Capoten)FDA LinkGeneric 06/2016 - 09/2002
7	Proteins (Proteins, Gene)FDA Link 01/2022 - 11/2019
6	CytokinesIBA 09/2023 - 04/2002
6	IronIBA 11/2019 - 11/2009
6	Angiotensin IIIBA 01/2018 - 09/2002
6	ferric carboxymaltoseIBA 05/2016 - 11/2009
5	lixisenatideIBA 01/2023 - 05/2015
5	Interleukin-6 (Interleukin 6)IBA 01/2022 - 04/2002
5	Enalapril FDA LinkGeneric 08/2021 - 01/2011
5	TroponinIBA 01/2021 - 03/2010
5	Valsartan (Vals)FDA Link 01/2020 - 01/2001
5	C-Reactive ProteinIBA 11/2019 - 11/2005
5	SodiumIBA 10/2017 - 11/2009
4	Insulin (Novolin)FDA Link 11/2022 - 02/2006
4	Growth Differentiation Factor 15IBA 01/2022 - 01/2012
4	Mineralocorticoid Receptor AntagonistsIBA 01/2021 - 10/2017
4	ReninIBA 01/2020 - 01/2011
3	HDL CholesterolIBA 01/2023 - 01/2018
3	Neprilysin (Neutral Endopeptidase)IBA 01/2023 - 07/2004
3	AdrenomedullinIBA 01/2023 - 06/2011
3	ChemokinesIBA 01/2022 - 11/2009
3	Fibroblast Growth Factor-23IBA 01/2022 - 01/2018
3	Serum AlbuminIBA 08/2021 - 11/2019
3	Sodium Potassium Chloride Symporter Inhibitors (Loop Diuretics)IBA 01/2021 - 01/2018
3	PotassiumIBA 01/2020 - 09/2014
3	AldosteroneIBA 01/2020 - 12/2012
3	Eplerenone (Inspra)FDA LinkGeneric 01/2020 - 09/2005
3	Troponin IIBA 01/2018 - 11/2012
3	Troponin T (Troponin T1)IBA 01/2016 - 11/2009
3	Hemoglobins (Hemoglobin)IBA 12/2009 - 09/2007
3	Atrial Natriuretic Factor (ANF)IBA 08/2009 - 09/2005
3	Chromogranin AIBA 06/2008 - 01/2003
2	SeleniumIBA 12/2023 - 08/2020
2	DiureticsIBA 01/2023 - 01/2022
2	Angiotensin Receptors (Angiotensin II Receptor)IBA 01/2023 - 10/2015
2	AnticoagulantsIBA 11/2022 - 11/2017
2	LigandsIBA 01/2022 - 06/2005
2	Lipocalin-2IBA 01/2022 - 05/2009
2	Sildenafil Citrate (Viagra)FDA Link 01/2022 - 01/2013
2	sacubitril and valsartan sodium hydrate drug combinationIBA 08/2021 - 01/2020
2	ChloridesIBA 08/2021 - 02/2017
2	ProteomeIBA 01/2021 - 01/2020
2	HDL LipoproteinsIBA 01/2021 - 01/2018
2	Carvedilol (Coreg)FDA LinkGeneric 01/2020 - 01/2018
2	AngiotensinsIBA 01/2020 - 06/2016
2	Glucose (Dextrose)FDA LinkGeneric 01/2018 - 02/2006
2	Vasodilator Agents (Vasodilators)IBA 01/2017 - 07/2015

Therapy/Procedure

47	Therapeutics 01/2024 - 03/2005
27	Cardiac Resynchronization Therapy 12/2023 - 10/2009
6	Percutaneous Coronary Intervention 10/2017 - 05/2009
3	Implantable Defibrillators (Implantable Cardioverter-Defibrillator) 10/2019 - 12/2008
3	Patient Readmission 08/2015 - 02/2009
3	Critical Care (Surgical Intensive Care) 05/2010 - 10/2008
2	Drug Therapy (Chemotherapy) 12/2023 - 10/2017
2	Coronary Artery Bypass (Coronary Artery Bypass Surgery) 01/2019 - 03/2010
2	Defibrillators (Defibrillator) 01/2018 - 09/2011
2	Intravenous Infusions 01/2017 - 03/2016